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Abstract: The carbapenemase OXA-244 is a derivate of OXA-48, and its detection is very difficult
in laboratories. Here, we report the identification and genomic analysis of an Escherichia coli isolate
(28Eco12) harboring the blaOXA-244 gene identified in Colombia, South America. The 28Eco12 isolate
was identified during a retrospective study, and it was recovered from a patient treated in Colombia.
The complete nucleotide sequence was established using the PacBio platform. A comparative genomics
analysis with other blaOXA-244–harboring Escherichia coli strains was performed. The 28Eco12 isolate
belonged to sequence type (ST) 38, and its genome was composed of two molecules, a chromosome
of 5,343,367 bp and a plasmid of 92,027 bp, which belonged to the incompatibility group IncY and did
not harbor resistance genes. The blaOXA-244 gene was chromosomally encoded and mobilized by an
ISR1-related Tn6237 composite transposon. Notably, this transposon was inserted and located within
a new genomic island. To our knowledge, this is the first report of a blaOXA-244–harboring Escherichia
coli isolate in America. Our results suggest that the introduction of the OXA-244-producing E. coli
isolate was through clonal expansion of the ST38 pandemic clone. Other isolates producing OXA-244
could be circulating silently in America.
Keywords: blaOXA-244; Escherichia coli; carbapenems; resistance; Colombia
1. Introduction
The World Health Organization WHO has recognized carbapenem-resistant Enterobacteriaceae as
pathogens with critical priority for the development of new antibiotics [1]. OXA-244, a carbapenemase
belonging to the Class D family, is a derivate of OXA-48 and encoded by the blaOXA-244 gene. Although
there are multiple reports of OXA-48-producing isolates, reports of isolates harboring OXA-244 are
less frequent, perhaps because their detection is difficult due to their reduced carbapenem activity.
The blaOXA-244 gene was initially described in 2011, within a Klebsiella pneumoniae isolate, which
was identified in Spain [2]. It has already been identified in Escherichia coli isolates recovered from
Germany [3], France [4,5], the United Kingdom [6], Southeast Asia [7], and Egypt [5]. The molecular
characterization of some of these E. coli isolates have shown that the majority of them belong to
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sequence type (ST) 38, although recently other STs have been found (ST361, ST1722, and ST3541) [5];
and they contain other β-lactamases, such as TEM, CTX-M, and CMY. The blaOXA-244 gene is located
in the chromosome within a truncated Tn1999.2 transposon, which is immersed into an ISR1-based
Tn6237 transposon [4,8]. Here, we provide a genomic analysis of an Escherichia coli isolate (28Eco12)
containing the blaOXA-244 gene that was recovered from a patient in Colombia, South America. To our
knowledge, this is the first report of a blaOXA-244–harboring Escherichia coli isolate in America.
2. Results
The 28Eco12 isolate was identified from a retrospective study in Bogotá, Colombia (see Materials
and Methods), and we decided to establish its complete genome to determine its resistome and mobile
genetic platform distribution (IS content). The genome was composed of two molecules, a chromosome
of 5,343,367 bp and a plasmid of 92,027 bp (p28Eco12), which belonged to the incompatibility group
IncY and did not harbor resistance genes. The resistance-genes arsenal of the isolate was composed of
aph(3′’)-Ib, aph(6)-Id, aaaA1 (aminoglycosides), blaOXA-244, blaCTX-M-14b, blaTEM-1b (beta-lactams), catA1
(chloramphenicol), sul2 (sulphonamides), dfrA1 (trimethoprim), and tetD (tetracycline) genes, all
chromosomally encoded (Figure 1). The 28Eco12 isolate belonged to ST38 [9]. The in silico serotyping
of the isolate was O102:H6.
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mobilization. The positions of the seven identical ISR1 and five IS1-family (89% of identity) sequences 
are also indicated. The strain positions on the figure are as follow (internal to external) (sequence 
type/serotype): K12 (ST10/O16:H48), F8111-1SC3 (ST182/O169:H41), 86J1 (ST361/O9:H30) MKGU01, 
62D3 (ST1722/O1:H25) MKGY01, 85H4 (ST3541/O53:H18) MKGW01, 73G4 (ST3541/O53:H18) MKGV01, 
266917_2 (ST38/O51:H30), 35J9 (ST38/O102:H6) MKGX01, 69E6 (ST38/O102:H6) MKGZ01, 78B5 
(ST38/O102:H6) MKGT01, and 28Eco12 (ST38/O102:H6) NZ_CP038505. 
Figure 1. BLASTn comparison of the blaOXA-244-containing Escherichia coli chromosomes. The K-12
(GenBank accession number NC_000913), F8111-1SC3 (GenBank accession number NZ_CP024269),
and 266917_2 (GenBank accession number NZ_CP026723.1) strains were used as references. At
the more external circle is shown the localization of the resistance genes and their putative genetic
platforms of mobilization. The positions of the seven identical ISR1 and five IS1-family (89% of identity)
sequences are also indicated. The strain positions on the figure are as follow (internal to external)
(sequence type/serotype): K12 (ST10/O16:H48), F8111-1SC3 (ST182/O169:H41), 86J1 (ST361/O9:H30)
MKGU01, 62D3 (ST1722/O1:H25) MKGY01, 85H4 (ST3541/O53:H18) MKGW01, 73G4 (ST3541/O53:H18)
MKGV01, 266917_2 (ST38/O51:H30), 35J9 (ST38/O102:H6) MKGX01, 69E6 (ST38/O102:H6) MKGZ01,
78B5 (ST38/O102:H6) MKGT01, and 28Eco12 (ST38/O102:H6) NZ_CP038505.
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Using the complete genome sequence, the 28Eco12 isolate was found to have a close genetic
relationship with the E. coli strain 266917_2 (ST38), described recently in the United Kingdom
(90% coverage, 97% identity, GenBank accession number CP026723.1), which does not contain
the blaOXA-244 gene. The genomic comparative analysis revealed that the blaOXA-244 gene was
mobilized by the Tn6237 transposon, as it has previously been described in Escherichia coli strain
VAL [4,8]. However, in the 28Eco12 isolate, the Tn6237 transposon was not inserted within the II536
pathogenicity island, as was previously reported to blaOXA-48 [8], but into a new putative genomic
island, inserted within the tRNA-sec gene. Its insertion produced a 39 bp direct repeat sequence
(TTCGACTCCTGTGATCTTCCGCCAATTAACATCTTCTGA). This event did not change the tRNA-sec
gene sequence (Figure 2).
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The putative island was also present in the blaOXA-244-negative enterotoxigenic E. coli F8111-1SC3
isolate (GenBank accession number NZ_CP024269). Interestingly, the tRNA-sec gene is a hot spot
for DNA insertion, because it also serves as the insertion site of the I536 pathogenicity island in the
uropathogenic strain E. coli 536 [10]. These results suggest that the Tn6237 transposon is active and
moves to different sites in the E. coli chromosome. In addition, the isolate harbored 69 insertion
sequences (IS) belonging to 17 different IS families (Table 1). Some of these present as single copy,
partial form, or multiple copies. The most frequent IS families were IS1, IS200/IS605_ssgr_IS200, and IS3,
with 13, 10, and 8 IS copies, respectively. Target site duplications (TSD) are signatures of transposition
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events, and among the 69 ISs, 25 presented TSDs and none were present within the E. coli F8111-1SC3
isolate, indicating that they were inserted by single-copy transposition. The TSD pattern analysis also
revealed the presence of two composite transposons, the Tn6237 (mentioned previously) and a 15,730
bp IS26-made transposon, which was inserted within a gene that encodes a hypothetical protein and
mobilizes the aph(3′’)-Ib, aph(6)-Id, blaTEM-1b (two copies), catA1, sul2, and tetD genes. Notably, this IS26
transposon was also inserted within another putative genomic island, which was inserted into the
tRNA-leu gene. The comparative analysis suggested that this IS26 transposon was mobilized from a
plasmid because it harbored the repA gene that corresponds to the incompatibility group IncQ-1 and
possesses DNA fragments with a high percentage of identity to pD90-1 and pEC141 plasmids, which
were identified in mcr-1-containing Salmonella enterica and E. coli strains, respectively [11]. With respect
to the other resistance genes, the blaCTX-M gene was mobilized by ISEcp1 and an IS26 remnant, which
were inserted within a gene that encodes a hypothetical protein.
Table 1. Insertion sequences identified in 28Eco12 isolate. Target site duplications (TSD) are shown in
bold and underlined.
IS Family IS Position Right and Left FlankingSequences Comments
IS1
IS1R 102025..102792 TGAATTGCT AAGAATGTT Composite transposon harboring the
blaOXA-244 gene.IS1R 123120..123887 GGGGATTCT TGAATTGCT
IS1R 936063..936830 CAGACAACG CAGACAACG Single IS transposition. IS insertedwithin a putative prophage
IS1-like 975280..976060 GTCGCAACC TACAACGTT IS inserted within a putativeprophage
IS1-like 977300..978080 GACAATGTC CAATCTGCT IS inserted within a putativeprophage
IS1R 1007836..1008603 TGCTTTTCT TGCTTTTCT Single IS transposition. IS insertedwithin an intergenic region
IS1R 1015519..1016286 GCCAATTCG GCCAATTCG Single IS transposition. IS insertedwithin the cmtB gene
IS1-like 2087231.. 2087998 CGGTTTTGG GAAGAGTTC IS inserted within the hchA gene
IS1-like 3237236..3237910 - GAAATCCCC IS (truncated) inserted within aputative prophage
IS1-like 3266386..3267153 CTGCAAATC TACAACCGG IS inserted within a putativeprophage
IS1R 3972674..3973441 CTGCTCCTG CTGCTCCTG Single IS transposition. IS insertedwithin a hypothetical gene
IS1R 4845817..4846584 GACGGTATT CGGATGCTG IS inserted within the adiA gene
IS1H 5066636..5067399 CCGGTAAAC CTTCTGATG IS inserted within an intergenic region
IS200/
IS605_ssgr_IS200
IS200C 1127230..1127936 TTTT TTTT Single IS transposition. IS insertedwithin a T-rich region
IS200C 1690413..1691121 TTTT TTTT Single IS transposition. IS insertedwithin a T-rich region
IS200C 2442570..2443280 TTAA TTAA Single IS transposition. IS insertedwithin a T-rich region
IS200C 2481694..2482403 TTTT TTAT Single IS transposition. IS insertedwithin a T-rich region
IS200C 2990220..2990930 AAAA AAAA Single IS transposition. IS insertedwithin a T-rich region
IS200C 3058643..3059351 TAAA AAAA Single IS transposition. IS insertedwithin a T-rich region
IS200C 3060222..3060929 AAAA AAAA Single IS transposition. IS insertedwithin a T-rich region
IS200C 3271558..3272271 GCAA AAAA IS inserted within a putativeprophage
IS200C 3939865..3940573 CAAA AAAA Single IS transposition. IS insertedwithin a T-rich region
IS200C 3994005..3994713 AAAA AAAA Single IS transposition. IS insertedwithin a T-rich region
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Table 1. Cont.
IS Family IS Position Right and Left FlankingSequences Comments
IS3
IS600 3254256..3255501 CAA ACA IS inserted within a genomic island
ISSd1 949559..950499 CAGTT - IS (truncated) inserted within aputative prophage
ISSd1 3267154..3267978 - GGT IS (truncated) inserted within agenomic island
ISSfl10 951719..952045 - GTT IS (truncated) inserted within aputative prophage
IS3 3259199..3260456 TCAT TTTA IS inserted within a genomic island
IS3 3236998..3237235 - CTTC IS (truncated) inserted within agenomic island
ISEc52 3249338..3250086 - - IS (truncated) inserted within agenomic island
ISEc52 3246586..3247067 - - IS (truncated) inserted within agenomic island
ISAs1
ISEc1 369367..369900 - CCCT
IS (truncated, formerly
Rhs-rearrangement hot-spots
element)
ISEc1 2456311..2456957 GATC -
IS (truncated, formerly
Rhs-rearrangement hot-spots
element)
ISEc1 3675287..3676199 TGTTGTAG TCCTTGGC IS (formerly Rhs-rearrangementhot-spots element)
ISEc1 3815490..3816780 GATGTATA CCTGCTCA IS (formerly Rhs-rearrangementhot-spots element)
ISEc1 4160599..4161889 TTCCTTCC CACTTCAC IS (formerly Rhs-rearrangementhot-spots element)
ISEc1 5069737..5071026 AGACCAGT GCATGTCA IS (formerly Rhs-rearrangementhot-spots element)
IS6
IS26 4500893..4501712 AAATCATG ATATCAAG
Composite transposon harboring the
blaTEM-1B (two copies), catA1,
aph(6′)-id, aph(3′’)-ib, sul2, and tetD
genes.
IS26 4503629..4504448 ATATCGGC GGTAAATC
IS26 4509192..4510011 CCGGCAAT GTAAGCTG
IS26 4513665..4514484 ACCATTTG CGCTGCGG
IS26 4515814..4516633 CAACAGGG AAATCATG
IS200/
IS605
IS609 3978710..3980457 CTCA ATAA IS inserted within the yajI gene
IS609 4689442..4691189 TGTG ATAA IS inserted within an intergenic region
IS609 2110716..2111379 - - IS (truncated) inserted within theyedK gene
ISEc46 2191062..2192824 TCAT CTAA IS inserted within an intergenic region
IS3 ssgr IS150
IS1397 1214273..1215704 TCAA TCAA Single IS transposition within anintergenic region
IS1397 1368490..1369921 TGGC TGGC Single IS transposition within anintergenic region
IS150 259853..261295 AAG AAG Single IS transposition within anintergenic region
IS150 2414087..2415529 GTT GTT Single IS transposition. IS insertedwithin a genomic island
IS3_ssgr_IS2
IS2 937126..938456 GTGGT TTGTC IS inserted within a putativeprophage
IS2 966497.. 967827 CCGCC ACGGT IS inserted within a putativeprophage
IS2 2027528..2028858 CCTTT CCTTT Single IS transposition. IS insertedwithin a genomic island
IS2 4799912..4800262 AAAAC - IS (truncated) inserted within aputative prophage
IS21
IS100Kyp 2015511..2017464 TTTGT TTTGT Single IS transposition. IS insertedwithin a genomic island
IS100Kyp 3273162..3275115 GTGATAAC GATAACAT IS inserted within a genomic island
IS100Kyp 4582722.. 4584675 TTCAGATG AGATGTAT IS inserted within a putativeprophage
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Table 1. Cont.
IS Family IS Position Right and Left FlankingSequences Comments
IS66
IS682 924827..926816 - CATGTATC IS (truncated) inserted within aputative prophage
ISEc22 923252..924827 ACAGAAGG - IS (truncated) inserted within aputative prophage
ISCro1 946022.. 948720 TTTTATCT TTTTATCT Single IS transposition. IS insertedwithin a putative prophage
IS3_ssgr_IS51
IS629 570569..571878 ATT ATT IS inserted within the acrF gene
IS1203 971759..973068 GATTACTG GTAATATC IS inserted within a putativeprophage
ISL3
ISKox3 970324..971101 - ATGTATCA IS (truncated) inserted within aputative prophage
ISEc38 2022594..2024315 AAAAGT ACTTTT
Single IS transposition. IS inserted
within a genomic island (inverted
TSD)
IS481 ISErp1 891175.. 892368 TATAATG TATAATG Single IS transposition. IS insertedwithin a putative prophage
IS30 IS30D 950498..951718 GT GT Single IS transposition. IS insertedwithin a putative prophage
IS4 IS10A 105162..106490 GGCCGAGC GTGCTGAAC IS inserted into IS1-compositetransposon
IS1380 ISEcp1 326913..330008 TTTA TTTA Single IS transposition. IS insertedwithin a hypothetical gene
IS110 IS5075 1568363..1569689 TT TT Single IS transposition. IS insertedwithin a hypothetical gene
3. Discussion
In this study, we perform the first report of an Escherichia coli isolate carrying the blaOXA-244 gene
in Colombia, South America. These blaOXA-244-positive isolates are less frequent (or perhaps they
circulate but are not detected) by their difficult detection and clonal dissemination. The multiresistant
28Eco12 isolate harbored only the phage-like IncY plasmid p28Eco12, which is genetically related to
the plasmids p266917_2_02 (88% coverage, 99% identity, GenBank accession number CP026725.1),
p1303_95 (91% coverage, 99% identity, GenBank accession number CP009168.1), p1 of Salmonella
enterica strain ty3-243 (90% coverage, 93% identity, GenBank accession number LT905089.1), and
the blaKPC-containing pCRKP-59-KPC (89% coverage, 94% identity, GenBank accession number
KX928752.1). Although this plasmid does not transport resistance genes, it appears to be conserved
in almost all blaOXA-244-containing E. coli strains included in our analysis, and its permanence is
perhaps caused by the presence of the P1 phd-doc toxin-antitoxin system that participates in host
post-segregational killing [12]. Currently, there is limited knowledge about this phage-like IncY-plasmid
family (for instance, the 37% of their ORFs is encoding for hypothetical proteins), but it is also becoming
a genetic platform to transport important resistance genes, such as blaCTX-M-15 and mcr-1; the latter
confers resistance to colistin [13].
All resistant genes were chromosomally located and mobilized by active composite transposons,
such as Tn6237, which has moved to different sites in the E. coli chromosome. In E. coli, the blaOXA-244
gene was disseminated mainly by ST38 clone in Europe and Asia [3–7]. However, non-ST38 E. coli
isolates are starting to appear in other countries, showing some genetic differences (Figure 1). As it is
known that ISs have an important impact on genetic variability, genome structure and function, and
foreign DNA acquisition, we try to decipher the potential of the 28Eco12 isolate to capture and move
more resistance genes through an analysis of the IS content and their TSD and flanking-sequences
patterns. Notably, this isolate has incorporated at least 69 ISs, showing a IS massive expansion
process [14]; the ISs-belonging family IS1 was the most active, with fifteen copies, in which four copies
probably were recently mobilized as single transposition events (unique copies) and two mobilized
as a composite transposon and responsible of the blaOXA-244-gene integration (Table 1). In spite of
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finding five IS26 copies, only two of these were mobilized as a composite transposon and transported
seven resistance genes. A study conducted by He et al. reported the IS26 participation in the plasmid
reorganization from clinical strains [15]. The high IS content found in this multiresistant E. coli isolate
indicates a high likelihood to acquire more resistance genes.
Finally, our institution searched for the presence of the blaOXA-244 gene within other
carbapenem-resistant E. coli isolates from 2013 to the present day, but none were positive. Considering
the time of the identification of the isolate, we believe that the E. coli isolate could have been acquired
in the remittent institution, suggesting an inter-institution dissemination. No additional information
could be obtained from the other institution.
4. Materials and Methods
The 28Eco12 isolate was identified from a retrospective study, conducted to characterize the
molecular mechanisms in carbapenem-resistant Enterobacteriaceae isolates, which were recovered
between 2013 and 2017, from a health institution in Bogotá, Colombia. The 28Eco12 isolate was
recovered from a male patient, in September 2013, who was transferred from another health institution
in the same city. The patient had suffered multiple traumas caused by a fall from a height of 20 m, and
he required treatment in the intensive-care unit for eleven days. The patient was transferred to our
institution, however, on the next day; the patient had fever, dysuria, urethral pain, leukocytosis, and
urethral purulent secretion, suggesting a possible catheter-associated urinary tract infection. From
a urine sample, the carbapenem-resistant Escherichia coli isolate 28Eco12 was identified, which was
also resistant to ampicillin/sulbactam, cefotaxime, ceftriaxone, cefepime, and aztreonam. The Hodge
Test was positive, and synergy and double-disc tests with boronic acid and EDTA were negative. The
patient was treated with meropenem (2 g every 8 h) and colistin (100 mg every 8 h), and thirteen days
later, he responded well to the treatment. No history of travel by him or his relatives was reported.
The complete genome sequence of the blaOXA-244-positive 28Eco12 isolate was obtained using the
PacBio RS II platform (Pacific Biosciences of California, Inc., Menlo Park, CA, USA) and assembled
through the previously reported procedure [16]. Briefly, sequencing reads were de novo assembled,
using the HGAP 3 protocol, and manually verified using BWA-MEM (Burrows–Wheeler Aligner
with maximal exact matches) [17] and Tablet v1.15.09.01 [18]. Misassembled terminal repeat overlap
sequences were identified with Gepard (Genome Pair Rapid Dotter) [19] and trimmed manually. The
genome was annotated using Prokka v1.11 [20], and the relevant regions were manually confirmed
using BLASTn and BLASTp and edited in Artemis [21]. The resistance-gene arsenal was identified
using ARIBA (https://github.com/sanger-pathogens/ariba/wiki), ResFinder [22], CARD [23], and
ARG-ANNOT databases [24]. The insertion sequences (IS) were found using ISsaga (http://issaga.
biotoul.fr/), and their flanking sequences were manually determined.
The study was approved by the ethics committee of the Shaio Clinic. The 28Eco12 complete
genome sequenced in this study is available in the DDBJ/EMBL/GenBank public databases, under the
accession numbers CP038505.1 and CP038506.1.
5. Conclusions
The isolates producing OXA-244 could be circulating in America and may not yet be identified,
perhaps due to their very low frequency, very difficult detection, or weakness in antimicrobial
resistance surveillance programs in some countries (such as Colombia). It is necessary to strengthen
the surveillance of last-line antibiotic resistance and move toward the implementation of molecular
and genomic tools for the detection of resistance genes in clinical settings.
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